COVID-19疑似心脏受累患者CMR心肌损伤的多中心研究
这项多中心回顾性研究纳入1047例PCR确诊COVID-19并接受CMR检查的患者,20.9%表现为非缺血性损伤模式(急性心肌炎7.9%,非急性/非缺血性13.0%),6.7%为缺血性模式(急性缺血1.9%,非急性/缺血性4.8%)。单因素分析显示胸痛、心电图异常、利钠肽升高和肌钙蛋白升高与急性心肌炎模式相关;多因素分析中肌钙蛋白升高与急性心肌炎模式独立相关(OR 4.98)。
要点
- COVID-19疑似心脏受累行CMR者约1/5存在非缺血性损伤,其中急性心肌炎占7.9%。
- 肌钙蛋白升高与急性心肌炎模式独立相关,OR达4.98。
- 已知冠心病患者出现急性缺血模式的OR高达33.30,需警惕缺血性损伤。
核心结论
- 在因临床怀疑心脏受累而转诊CMR的COVID-19患者中,非缺血性和缺血性心肌损伤模式均较常见,尤其当存在心脏症状、心电图异常和心脏生物标志物升高时。
研究设计与样本
- 多中心回顾性研究,纳入18个国际中心的1047例PCR确诊COVID-19且接受CMR检查的患者。
- CMR上将心肌损伤模式分为急性心肌炎、非急性/非缺血性、急性缺血性和非急性/缺血性四类。
关键影像表现/征象
- 20.9%的患者表现为非缺血性损伤模式,其中急性心肌炎7.9%、非急性/非缺血性13.0%。
- 6.7%的患者表现为缺血性损伤模式,其中急性缺血1.9%、非急性/缺血性4.8%。
诊断标准与关键数值
- 单因素分析中与急性心肌炎模式相关的变量:胸痛(OR 2.00,95%CI 1.17-3.40,P=0.01)、心电图异常(OR 1.90,95%CI 1.12-3.23,P=0.02)、利钠肽升高(OR 2.99,95%CI 1.60-5.58,P=0.0006)、肌钙蛋白升高(OR 4.21,95%CI 2.41-7.36,P<0.0001)。
- 单因素分析中与急性缺血模式相关的变量:胸痛(OR 3.14,95%CI 1.04-9.49,P=0.04)、心电图异常(OR 4.06,95%CI 1.10-14.92,P=0.04)、已知冠心病(OR 33.30,95%CI 4.04-274.53,P=0.001)、住院(OR 4.98,95%CI 1.55-16.05,P=0.007)、利钠肽升高(OR 4.19,95%CI 1.30-13.51,P=0.02)、肌钙蛋白升高(OR 25.27,95%CI 5.55-115.03,P<0.0001)。
- 多因素分析中肌钙蛋白升高与急性心肌炎模式独立相关(OR 4.98,95%CI 1.76-14.05,P=0.003)。
临床应用与阅片要点
- 对COVID-19疑似心脏受累患者,若肌钙蛋白升高应警惕急性心肌炎模式,建议转诊CMR进一步评估。
- 已知冠心病患者出现心脏症状或心电图异常时急性缺血模式风险高,阅片需优先排除缺血性损伤。
局限性
- 回顾性研究设计,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Myocardial injury in patients with COVID-19 and suspected cardiac involvement is not well understood.
OBJECTIVES: The purpose of this study was to characterize myocardial injury in a multicenter cohort of patients with COVID-19 and suspected cardiac involvement referred for cardiac magnetic resonance (CMR).
METHODS: This retrospective study consisted of 1,047 patients from 18 international sites with polymerase chain reaction-confirmed COVID-19 infection who underwent CMR. Myocardial injury was characterized as acute myocarditis, nonacute/nonischemic, acute ischemic, and nonacute/ischemic patterns on CMR.
RESULTS: In this cohort, 20.9% of patients had nonischemic injury patterns (acute myocarditis: 7.9%; nonacute/nonischemic: 13.0%), and 6.7% of patients had ischemic injury patterns (acute ischemic: 1.9%; nonacute/ischemic: 4.8%). In a univariate analysis, variables associated with acute myocarditis patterns included chest discomfort (OR: 2.00; 95% CI: 1.17-3.40, P = 0.01), abnormal electrocardiogram (ECG) (OR: 1.90; 95% CI: 1.12-3.23; P = 0.02), natriuretic peptide elevation (OR: 2.99; 95% CI: 1.60-5.58; P = 0.0006), and troponin elevation (OR: 4.21; 95% CI: 2.41-7.36; P < 0.0001). Variables associated with acute ischemic patterns included chest discomfort (OR: 3.14; 95% CI: 1.04-9.49; P = 0.04), abnormal ECG (OR: 4.06; 95% CI: 1.10-14.92; P = 0.04), known coronary disease (OR: 33.30; 95% CI: 4.04-274.53; P = 0.001), hospitalization (OR: 4.98; 95% CI: 1.55-16.05; P = 0.007), natriuretic peptide elevation (OR: 4.19; 95% CI: 1.30-13.51; P = 0.02), and troponin elevation (OR: 25.27; 95% CI: 5.55-115.03; P < 0.0001). In a multivariate analysis, troponin elevation was strongly associated with acute myocarditis patterns (OR: 4.98; 95% CI: 1.76-14.05; P = 0.003).
CONCLUSIONS: In this multicenter study of patients with COVID-19 with clinical suspicion for cardiac involvement referred for CMR, nonischemic and ischemic patterns were frequent when cardiac symptoms, ECG abnormalities, and cardiac biomarker elevations were present.
引用
- Vidula, Rajewska-Tabor, Cao, et al. Myocardial Injury on CMR in Patients With COVID-19 and Suspected Cardiac Involvement. JACC Cardiovasc Imaging. 2023. PMID: 36752429. doi:10.1016/j.jcmg.2022.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。